6ix — Find Your Next Investment

Discover investor relations events, company profiles, and opportunities on 6ix. Connect with public companies and attend live investor events.

Please enable JavaScript to use all features of 6ix.com.

Originaltext

Diese Übersetzung bewerten

Mit deinem Feedback können wir Google Übersetzer weiter verbessern

Latest Press Releases

Time	Headline
4m ago	Sierra Madre Receives Mexican Antitrust Approval for the Acquisition of the Del Toro Mine
4m ago	Terra Innovatum Provides Update on Form 10-K and First Quarter 2026 Reporting Timeline
5m ago	NANOBIOTIX Announces Full Exercise of Underwriters’ Over-Allotment Option, Bringing Gross Proceeds of Offering to Approximately $100 Million
5m ago	PHINIA Board Declares Quarterly Dividend of $0.30 per Common Share
5m ago	Angel Oak Financial Strategies Income Term Trust Issues Mandatorily Redeemable Preferred Shares and New Notes and Sets Record Date and Date for Annual Meeting of Shareholders

About

31.85USD+0.06 +0.19%

Closed • Updated at 20:42 GMT+00:00

Market Cap$1.52B

Volume435.9K

Beta1.65

RSI47.33

Health TechnologyBiotechnology

Mbx Biosciences, Inc. — investor relations, events, news, and company updates on 6ix.

Latest News

MBX Biosciences Provides Obesity Portfolio Update Including Initial Phase 1 Data for MBX 4291 Supporting Potential for Once-Monthly Dosing

MBX Biosciences Announces Appointment of Mark Soued as Chief Commercial Officer and Inducement Grant Award

MBX Biosciences to Host In-Person and Virtual Obesity Day on May 11, 2026 to Discuss Expanding Obesity Portfolio

MBX Biosciences Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Microbix Announces Annual Meeting Voting Results

Community Chat

Ask AI